enzymmanagement ag develops and produces bioactive cosmeceutical and topical treatments targeting benign fatty‑tissue tumors and certain rare diseases such as multiple symmetric lipomatosis and estradiol‑dependent breast cancer. Its developments are based on intracrinological and biochemical principles of local steroid production and metabolism in target tissues.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentCosmetics Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Patenting, development and production of biologically active cosmeceuticals and topical therapies
Patenting, development and production of biologically active cosmeceuticals and topical therapies for benign tumours of adipose tissue and rare diseases.
Development of therapies for rare diseases
Therapies for rare diseases such as multiple symmetric lipomatosis (Madelung’s disease) and oestrogen receptor-positive breast cancer.
Cooperation, marketing and distribution partnerships
Search for international cooperation, marketing and/or distribution partners for its own developments and patents.
Knowledge
No knowledge articles yet
Once enzymmanagement ag has claimed this profile, we'll publish editorial articles and case studies here together.